IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v13y2022i1d10.1038_s41467-022-35055-1.html
   My bibliography  Save this article

High antibody levels and reduced cellular response in children up to one year after SARS-CoV-2 infection

Author

Listed:
  • Eva-Maria Jacobsen

    (Ulm University Medical Center, Ulm University)

  • Dorit Fabricius

    (Ulm University Medical Center, Ulm University)

  • Magdalena Class

    (Ulm University Medical Center, Ulm University)

  • Fernando Topfstedt

    (Medical Center University of Freiburg, Faculty of Medicine, University of Freiburg)

  • Raquel Lorenzetti

    (Medical Center University of Freiburg, Faculty of Medicine, University of Freiburg)

  • Iga Janowska

    (Medical Center University of Freiburg, Faculty of Medicine, University of Freiburg)

  • Franziska Schmidt

    (Medical Center University of Freiburg, Faculty of Medicine, University of Freiburg)

  • Julian Staniek

    (Medical Center University of Freiburg, Faculty of Medicine, University of Freiburg)

  • Maria Zernickel

    (Ulm University Medical Center, Ulm University)

  • Thomas Stamminger

    (Ulm University Medical Center)

  • Andrea N. Dietz

    (Ulm University Medical Center)

  • Angela Zellmer

    (CANDOR Bioscience GmbH)

  • Manuel Hecht

    (CANDOR Bioscience GmbH)

  • Peter Rauch

    (CANDOR Bioscience GmbH)

  • Carmen Blum

    (Ulm University Medical Center, Ulm University)

  • Carolin Ludwig

    (Ulm University
    German Red Cross Blood Transfusion Service Baden-Württemberg – Hessen and University Hospital Ulm)

  • Bernd Jahrsdörfer

    (Ulm University
    German Red Cross Blood Transfusion Service Baden-Württemberg – Hessen and University Hospital Ulm)

  • Hubert Schrezenmeier

    (Ulm University
    German Red Cross Blood Transfusion Service Baden-Württemberg – Hessen and University Hospital Ulm)

  • Maximilian Heeg

    (Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg)

  • Benjamin Mayer

    (University of Ulm)

  • Alina Seidel

    (Ulm University Medical Center)

  • Rüdiger Groß

    (Ulm University Medical Center)

  • Jan Münch

    (Ulm University Medical Center)

  • Frank Kirchhoff

    (Ulm University Medical Center)

  • Sebastian F. N. Bode

    (Ulm University Medical Center, Ulm University)

  • Gudrun Strauss

    (Ulm University Medical Center, Ulm University)

  • Hanna Renk

    (University Children’s Hospital Tuebingen)

  • Roland Elling

    (Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg
    University of Freiburg)

  • Maximillian Stich

    (University Children’s Hospital Heidelberg)

  • Reinhard E. Voll

    (Medical Center University of Freiburg, Faculty of Medicine, University of Freiburg
    Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg)

  • Burkhard Tönshof

    (University Children’s Hospital Heidelberg)

  • Axel R. Franz

    (University Children’s Hospital Tuebingen)

  • Philipp Henneke

    (Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg
    University of Freiburg)

  • Klaus-Michael Debatin

    (Ulm University Medical Center, Ulm University)

  • Marta Rizzi

    (Medical Center University of Freiburg, Faculty of Medicine, University of Freiburg
    Albert-Ludwigs University
    Vienna Medical University of Vienna)

  • Ales Janda

    (Ulm University Medical Center, Ulm University)

Abstract

The COVID-19 course and immunity differ in children and adults. We analyzed immune response dynamics in 28 families up to 12 months after mild or asymptomatic infection. Unlike adults, the initial response is plasmablast-driven in children. Four months after infection, children show an enhanced specific antibody response and lower but detectable spike 1 protein (S1)-specific B and T cell responses than their parents. While specific antibodies decline, neutralizing antibody activity and breadth increase in both groups. The frequencies of S1-specific B and T cell responses remain stable. However, in children, one year after infection, an increase in the S1-specific IgA class switch and the expression of CD27 on S1-specific B cells and T cell maturation are observed. These results, together with the enhanced neutralizing potential and breadth of the specific antibodies, suggest a progressive maturation of the S1-specific immune response. Hence, the immune response in children persists over 12 months but dynamically changes in quality, with progressive neutralizing, breadth, and memory maturation. This implies a benefit for booster vaccination in children to consolidate memory formation.

Suggested Citation

  • Eva-Maria Jacobsen & Dorit Fabricius & Magdalena Class & Fernando Topfstedt & Raquel Lorenzetti & Iga Janowska & Franziska Schmidt & Julian Staniek & Maria Zernickel & Thomas Stamminger & Andrea N. Di, 2022. "High antibody levels and reduced cellular response in children up to one year after SARS-CoV-2 infection," Nature Communications, Nature, vol. 13(1), pages 1-16, December.
  • Handle: RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-35055-1
    DOI: 10.1038/s41467-022-35055-1
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-022-35055-1
    File Function: Abstract
    Download Restriction: no

    File URL: https://libkey.io/10.1038/s41467-022-35055-1?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Chengqian Feng & Jingrong Shi & Qinghong Fan & Yaping Wang & Huang Huang & Fengjuan Chen & Guofang Tang & Youxia Li & Pingchao Li & Jiaojiao Li & Jianping Cui & Liliangzi Guo & Sisi Chen & Mengling Ji, 2021. "Protective humoral and cellular immune responses to SARS-CoV-2 persist up to 1 year after recovery," Nature Communications, Nature, vol. 12(1), pages 1-7, December.
    2. Valerie Oberhardt & Hendrik Luxenburger & Janine Kemming & Isabel Schulien & Kevin Ciminski & Sebastian Giese & Benedikt Csernalabics & Julia Lang-Meli & Iga Janowska & Julian Staniek & Katharina Wild, 2021. "Rapid and stable mobilization of CD8+ T cells by SARS-CoV-2 mRNA vaccine," Nature, Nature, vol. 597(7875), pages 268-273, September.
    3. Christopher O. Barnes & Claudia A. Jette & Morgan E. Abernathy & Kim-Marie A. Dam & Shannon R. Esswein & Harry B. Gristick & Andrey G. Malyutin & Naima G. Sharaf & Kathryn E. Huey-Tubman & Yu E. Lee &, 2020. "SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies," Nature, Nature, vol. 588(7839), pages 682-687, December.
    4. Christian Gaebler & Zijun Wang & Julio C. C. Lorenzi & Frauke Muecksch & Shlomo Finkin & Minami Tokuyama & Alice Cho & Mila Jankovic & Dennis Schaefer-Babajew & Thiago Y. Oliveira & Melissa Cipolla & , 2021. "Evolution of antibody immunity to SARS-CoV-2," Nature, Nature, vol. 591(7851), pages 639-644, March.
    5. Zijun Wang & Frauke Muecksch & Dennis Schaefer-Babajew & Shlomo Finkin & Charlotte Viant & Christian Gaebler & Hans- Heinrich Hoffmann & Christopher O. Barnes & Melissa Cipolla & Victor Ramos & Thiago, 2021. "Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection," Nature, Nature, vol. 595(7867), pages 426-431, July.
    6. Hanna Renk & Alex Dulovic & Alina Seidel & Matthias Becker & Dorit Fabricius & Maria Zernickel & Daniel Junker & Rüdiger Groß & Janis Müller & Alexander Hilger & Sebastian F. N. Bode & Linus Fritsch &, 2022. "Robust and durable serological response following pediatric SARS-CoV-2 infection," Nature Communications, Nature, vol. 13(1), pages 1-11, December.
    7. Julian Braun & Lucie Loyal & Marco Frentsch & Daniel Wendisch & Philipp Georg & Florian Kurth & Stefan Hippenstiel & Manuela Dingeldey & Beate Kruse & Florent Fauchere & Emre Baysal & Maike Mangold & , 2020. "SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19," Nature, Nature, vol. 587(7833), pages 270-274, November.
    8. Alice Cho & Frauke Muecksch & Dennis Schaefer-Babajew & Zijun Wang & Shlomo Finkin & Christian Gaebler & Victor Ramos & Melissa Cipolla & Pilar Mendoza & Marianna Agudelo & Eva Bednarski & Justin DaSi, 2021. "Anti-SARS-CoV-2 receptor-binding domain antibody evolution after mRNA vaccination," Nature, Nature, vol. 600(7889), pages 517-522, December.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Leander Witte & Viren A. Baharani & Fabian Schmidt & Zijun Wang & Alice Cho & Raphael Raspe & Camila Guzman-Cardozo & Frauke Muecksch & Marie Canis & Debby J. Park & Christian Gaebler & Marina Caskey , 2023. "Epistasis lowers the genetic barrier to SARS-CoV-2 neutralizing antibody escape," Nature Communications, Nature, vol. 14(1), pages 1-11, December.
    2. Haisheng Yu & Banghui Liu & Yudi Zhang & Xijie Gao & Qian Wang & Haitao Xiang & Xiaofang Peng & Caixia Xie & Yaping Wang & Peiyu Hu & Jingrong Shi & Quan Shi & Pingqian Zheng & Chengqian Feng & Guofan, 2023. "Somatically hypermutated antibodies isolated from SARS-CoV-2 Delta infected patients cross-neutralize heterologous variants," Nature Communications, Nature, vol. 14(1), pages 1-14, December.
    3. Mark Chernyshev & Mrunal Sakharkar & Ruth I. Connor & Haley L. Dugan & Daniel J. Sheward & C. G. Rappazzo & Aron Stålmarck & Mattias N. E. Forsell & Peter F. Wright & Martin Corcoran & Ben Murrell & L, 2023. "Vaccination of SARS-CoV-2-infected individuals expands a broad range of clonally diverse affinity-matured B cell lineages," Nature Communications, Nature, vol. 14(1), pages 1-12, December.
    4. Leire Campos-Mata & Benjamin Trinité & Andrea Modrego & Sonia Tejedor Vaquero & Edwards Pradenas & Anna Pons-Grífols & Natalia Rodrigo Melero & Diego Carlero & Silvia Marfil & César Santiago & Dàlia R, 2024. "A monoclonal antibody targeting a large surface of the receptor binding motif shows pan-neutralizing SARS-CoV-2 activity," Nature Communications, Nature, vol. 15(1), pages 1-13, December.
    5. Emanuele Andreano & Ida Paciello & Silvia Marchese & Lorena Donnici & Giulio Pierleoni & Giulia Piccini & Noemi Manganaro & Elisa Pantano & Valentina Abbiento & Piero Pileri & Linda Benincasa & Ginevr, 2022. "Anatomy of Omicron BA.1 and BA.2 neutralizing antibodies in COVID-19 mRNA vaccinees," Nature Communications, Nature, vol. 13(1), pages 1-8, December.
    6. Dominik Menges & Kyra D. Zens & Tala Ballouz & Nicole Caduff & Daniel Llanas-Cornejo & Hélène E. Aschmann & Anja Domenghino & Céline Pellaton & Matthieu Perreau & Craig Fenwick & Giuseppe Pantaleo & C, 2022. "Heterogenous humoral and cellular immune responses with distinct trajectories post-SARS-CoV-2 infection in a population-based cohort," Nature Communications, Nature, vol. 13(1), pages 1-16, December.
    7. Yubin Liu & Ziyi Wang & Xinyu Zhuang & Shengnan Zhang & Zhicheng Chen & Yan Zou & Jie Sheng & Tianpeng Li & Wanbo Tai & Jinfang Yu & Yanqun Wang & Zhaoyong Zhang & Yunfeng Chen & Liangqin Tong & Xi Yu, 2023. "Inactivated vaccine-elicited potent antibodies can broadly neutralize SARS-CoV-2 circulating variants," Nature Communications, Nature, vol. 14(1), pages 1-17, December.
    8. Dhiraj Mannar & James W. Saville & Chad Poloni & Xing Zhu & Alison Bezeruk & Keith Tidey & Sana Ahmed & Katharine S. Tuttle & Faezeh Vahdatihassani & Spencer Cholak & Laura Cook & Theodore S. Steiner , 2024. "Altered receptor binding, antibody evasion and retention of T cell recognition by the SARS-CoV-2 XBB.1.5 spike protein," Nature Communications, Nature, vol. 15(1), pages 1-11, December.
    9. Kevin J. Kramer & Erin M. Wilfong & Kelsey Voss & Sierra M. Barone & Andrea R. Shiakolas & Nagarajan Raju & Caroline E. Roe & Naveenchandra Suryadevara & Lauren M. Walker & Steven C. Wall & Ariana Pau, 2022. "Single-cell profiling of the antigen-specific response to BNT162b2 SARS-CoV-2 RNA vaccine," Nature Communications, Nature, vol. 13(1), pages 1-20, December.
    10. Wenkai Han & Ningning Chen & Xinzhou Xu & Adil Sahil & Juexiao Zhou & Zhongxiao Li & Huawen Zhong & Elva Gao & Ruochi Zhang & Yu Wang & Shiwei Sun & Peter Pak-Hang Cheung & Xin Gao, 2023. "Predicting the antigenic evolution of SARS-COV-2 with deep learning," Nature Communications, Nature, vol. 14(1), pages 1-14, December.
    11. Seoryeong Park & Jaewon Choi & Yonghee Lee & Jinsung Noh & Namphil Kim & JinAh Lee & Geummi Cho & Sujeong Kim & Duck Kyun Yoo & Chang Kyung Kang & Pyoeng Gyun Choe & Nam Joong Kim & Wan Beom Park & Se, 2024. "An ancestral SARS-CoV-2 vaccine induces anti-Omicron variants antibodies by hypermutation," Nature Communications, Nature, vol. 15(1), pages 1-9, December.
    12. Ramon Roozendaal & Laura Solforosi & Daniel J. Stieh & Jan Serroyen & Roel Straetemans & Anna Dari & Muriel Boulton & Frank Wegmann & Sietske K. Rosendahl Huber & Joan E. M. van der Lubbe & Jenny Hend, 2021. "SARS-CoV-2 binding and neutralizing antibody levels after Ad26.COV2.S vaccination predict durable protection in rhesus macaques," Nature Communications, Nature, vol. 12(1), pages 1-10, December.
    13. Meng Wang & Adeline Dehlinger & Camila Fernández Zapata & Maya Golan & Gerardina Gallaccio & Leif E. Sander & Stephan Schlickeiser & Desiree Kunkel & Tanja Schmitz-Hübsch & Birgit Sawitzki & Arnon Kar, 2023. "Associations of myeloid cells with cellular and humoral responses following vaccinations in patients with neuroimmunological diseases," Nature Communications, Nature, vol. 14(1), pages 1-15, December.
    14. Meriem Bekliz & Kenneth Adea & Pauline Vetter & Christiane S. Eberhardt & Krisztina Hosszu-Fellous & Diem-Lan Vu & Olha Puhach & Manel Essaidi-Laziosi & Sophie Waldvogel-Abramowski & Caroline Stephan , 2022. "Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCs," Nature Communications, Nature, vol. 13(1), pages 1-10, December.
    15. Wanbo Tai & Shengyong Feng & Benjie Chai & Shuaiyao Lu & Guangyu Zhao & Dong Chen & Wenhai Yu & Liting Ren & Huicheng Shi & Jing Lu & Zhuming Cai & Mujia Pang & Xu Tan & Penghua Wang & Jinzhong Lin & , 2023. "An mRNA-based T-cell-inducing antigen strengthens COVID-19 vaccine against SARS-CoV-2 variants," Nature Communications, Nature, vol. 14(1), pages 1-15, December.
    16. Lisa-Marie Funk & Gereon Poschmann & Fabian Rabe von Pappenheim & Ashwin Chari & Kim M. Stegmann & Antje Dickmanns & Marie Wensien & Nora Eulig & Elham Paknia & Gabi Heyne & Elke Penka & Arwen R. Pear, 2024. "Multiple redox switches of the SARS-CoV-2 main protease in vitro provide opportunities for drug design," Nature Communications, Nature, vol. 15(1), pages 1-18, December.
    17. Rajeshwer S. Sankhala & Kerri G. Lal & Jaime L. Jensen & Vincent Dussupt & Letzibeth Mendez-Rivera & Hongjun Bai & Lindsay Wieczorek & Sandra V. Mayer & Michelle Zemil & Danielle A. Wagner & Samantha , 2024. "Diverse array of neutralizing antibodies elicited upon Spike Ferritin Nanoparticle vaccination in rhesus macaques," Nature Communications, Nature, vol. 15(1), pages 1-19, December.
    18. Tianqi Song & Yishi Wang & Xi Gu & Sijia Qiao, 2023. "Modeling the Within-Host Dynamics of SARS-CoV-2 Infection Based on Antiviral Treatment," Mathematics, MDPI, vol. 11(16), pages 1-19, August.
    19. Grace Kenny & Sophie O’Reilly & Neil Wrigley Kelly & Riya Negi & Colette Gaillard & Dana Alalwan & Gurvin Saini & Tamara Alrawahneh & Nathan Francois & Matthew Angeliadis & Alejandro Abner Garcia Leon, 2023. "Distinct receptor binding domain IgG thresholds predict protective host immunity across SARS-CoV-2 variants and time," Nature Communications, Nature, vol. 14(1), pages 1-11, December.
    20. Daniel M. Altmann & Catherine J. Reynolds & George Joy & Ashley D. Otter & Joseph M. Gibbons & Corinna Pade & Leo Swadling & Mala K. Maini & Tim Brooks & Amanda Semper & Áine McKnight & Mahdad Noursad, 2023. "Persistent symptoms after COVID-19 are not associated with differential SARS-CoV-2 antibody or T cell immunity," Nature Communications, Nature, vol. 14(1), pages 1-9, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-35055-1. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.